{"id":3207,"date":"2013-10-25T08:30:00","date_gmt":"2013-10-25T08:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion\/"},"modified":"2013-10-25T08:30:00","modified_gmt":"2013-10-25T08:30:00","slug":"dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion\/","title":{"rendered":"Dr. Joel Cooper accepted to be new Medical Advisor to XVIVO perfusion"},"content":{"rendered":"
Dr. Joel Cooper became the first surgeon in the world to complete the first successful lung transplant.\u00a0 Dr. Cooper, who recently accepted an appointment to become the Medical Advisor to XVIVO Perfusion, is an internationally recognized surgeon and scientist renowned for his pioneering techniques and progress in the treatment of lung diseases.<\/strong><\/div>\n

This year, the 6th of November, the medical field of transplantation celebrates the 30th anniversary of the first successful lung transplantation performed by Dr. Cooper and his surgical team at the University of Toronto. In 1983, November 7, the world\u00b4s first successful single-lung transplant operation was performed at Toronto General Hospital by a team led by Dr. Joel Cooper. The patient lived an active life for 6 years before passing away from kidney failure at the age of 64. Some years later Dr. Cooper also performed the world\u00b4s first successful clinical double lung transplants in St Louis, Missouri, USA. <\/span><\/p>\n

Dr. Cooper, who recently accepted an appointment to be the Medical Advisor to XVIVO Perfusion, is an internationally recognized surgeon and scientist who has dedicated his time and work in experimental and clinical lung transplantation. He is known for his pioneering techniques and has received numerous honors and prestigious awards over the years. Dr. Cooper is member of editorial boards, author and coauthor of more than 400 peer-reviewed scientific articles. Besides lung transplantation, Dr Cooper\u2019s main clinical interests include general thoracic surgery, lung volume reduction surgery for emphysema, myasthenia gravis, gastro esophageal reflux, and esophageal cancer.<\/span><\/p>\n

Dr. Cooper recently stepped down from his position as the Chief of the Division of Thoracic Surgery at UPHS, Philadelphia, Pennsylvania, USA. Prior to Dr Cooper\u00b4s position at UPHS, Dr. Cooper served as the Professor of Surgery and Chief of the Division of Cardiothoracic Surgery at Washington University and Barnes-Jewish Hospital in St. Louis and before that as Surgical Director of the lung transplant group at Toronto General Hospital.<\/span><\/p>\n

Dr. Cooper will be working as Medical Advisor for XVIVO, specifically in Research and Development for new products and solutions in lung transplantation.<\/span><\/p>\n

\u201cWe are very excited that Dr. Cooper accepted the position of Medical Advisor for XVIVO. Dr. Cooper\u2019s pioneering work in developing clinical lung transplantation to what it is today was indeed ground breaking. Dr. Cooper\u2019s work has always been in the forefront both in terms of basic and clinical research and development and many of today\u2019s leaders have been fostered under his supervision. Since Dr. Cooper has great knowledge, experience and contacts in the field of thoracic surgery we are very excited to have the opportunity to develop a close relationship with him and are certain that it will help XVIVO to further develop the company\u2019s core technology \u2013 Ex Vivo perfusion of organs at normothermic temperatures.\u201d says Dr. Magnus Nilsson, CEO, XVIVO Perfusion.<\/span><\/p>\n

October 25, 2013
Gothenburg
XVIVO Perfusion AB (publ)<\/span><\/p>\n

\n

For further information please contact:
<\/span>
Christoffer Rosenblad, CFO, tel: +46 31\u00a0788 21 59, e-mail: christoffer.rosenblad@xvivoperfusion.com<\/a><\/span>
For further information on XVIVO Perfusion\u2019s business, please refer to the company\u2019s website, www.xvivoperfusion.com<\/a><\/span><\/p>\n

Xvivo Perfusion is required to publish the information in this press release in accordance with the Swedish Securities Market Act and\/or the Financial Instruments Trading Act. The information was submitted for publication on\u00a0October 25, 2013\u00a0at 10:30 a.m.<\/span><\/p>\n

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Dr. Joel Cooper became the first surgeon in the world to complete the first successful lung transplant.\u00a0 Dr. Cooper, who…<\/p>\n","protected":false},"template":"","class_list":["post-3207","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-vpml","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-staff"],"acf":[],"yoast_head":"\nDr. Joel Cooper accepted to be new Medical Advisor to XVIVO perfusion - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dr. Joel Cooper accepted to be new Medical Advisor to XVIVO perfusion - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Dr. Joel Cooper became the first surgeon in the world to complete the first successful lung transplant.\u00a0 Dr. Cooper, who...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion\\\/\",\"name\":\"Dr. Joel Cooper accepted to be new Medical Advisor to XVIVO perfusion - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2013-10-25T08:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dr. Joel Cooper accepted to be new Medical Advisor to XVIVO perfusion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dr. Joel Cooper accepted to be new Medical Advisor to XVIVO perfusion - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion\/","og_locale":"en_US","og_type":"article","og_title":"Dr. Joel Cooper accepted to be new Medical Advisor to XVIVO perfusion - XVIVO","og_description":"Dr. Joel Cooper became the first surgeon in the world to complete the first successful lung transplant.\u00a0 Dr. Cooper, who...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion\/","name":"Dr. Joel Cooper accepted to be new Medical Advisor to XVIVO perfusion - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2013-10-25T08:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/dr-joel-cooper-accepted-to-be-new-medical-advisor-to-xvivo-perfusion\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"Dr. Joel Cooper accepted to be new Medical Advisor to XVIVO perfusion"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3207","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3207"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}